Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

(2011) Claudio Belluco et al.   ANNALS OF SURGICAL ONCOLOGY

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

(2011) Stuart J. Wong et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

(2011) Carlo Aschele et al.   JOURNAL OF CLINICAL ONCOLOGY

Downstaging Without Complete Pathologic Response After Neoadjuvant Treatment Improves Cancer Outcomes for cIII but not cII Rectal Cancers

(2010) Luiz Felipe de Campos-Lobato et al.   ANNALS OF SURGICAL ONCOLOGY

Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer

(2010) Y. Ishii et al.   EJSO

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

(2010) Jean-Pierre Gérard et al.   JOURNAL OF CLINICAL ONCOLOGY

Capecitabine for locally advanced and metastatic colorectal cancer: A review

(2010) Georgios V Koukourakis   World Journal of Gastrointestinal Oncology

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Neoadjuvant Capecitabine Combined with Standard Radiotherapy in Patients with Locally Advanced Rectal Cancer

(2008) Juergen Dunst et al.   STRAHLENTHERAPIE UND ONKOLOGIE